Podcasts about mckesson corporation

For our final Engineering spotlight this month, I sit down with Brent Wunderlich. Brent Wunderlich is an experienced people leader with a proven track record in optimizing healthcare supply chain operations. He has been with McKesson Corporation for 22 years, currently serving as Vice President of Strategic Initiatives & Insights.  Brent collaborates with internal and external partners to drive large-scale projects and strategic initiatives. With a background in engineering and analytics, Brent leverages data to improve supply chain performance and has held various leadership roles within McKesson.  He holds a B.S. in Industrial Engineering from Purdue University.  Brent is also actively involved in community organizations, holding board positions with several local non-profit and community organizations.

Let us know your thoughts. Send us a Text Message. Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedInEpisode Title:

Der Tabakwarenhersteller sieht sich mit rückläufigen Raucherzahlen konfrontiert. Rüdiger und Robert analysieren, welche Auswirkungen das auf die Aktie hat.Erwähnte Titel: Philip Morris, Nvidia, BYD, Nio, Fisker, Hyundai Motor, McKesson Corporation, Lenzing, L'Occitane, Pepsi, StarbucksAlle Folgen finden Sie auch auf KURIER.at und kronehit.at.Weitere Podcasts finden Sie unter KURIER.at/podcasts Hosted on Acast. See acast.com/privacy for more information.

Tercera hora de Visión Global que dedicamos a nuestro consultorio de Wall Street en el que nos acompaña Miguel Ángel Martínez, gestor de mercados en Tiempo de Bolsa. Con él, analizamos compañías como Nvidia, Arch Capital, MacDonalds, Starbucks, Constellation Software, McKesson Corporation, AMC Entertainment Holdings, MSC Industrial Direct Co, Lotus Bakeries NV, Super Micro Computer. Después, último vistazo a los índices de Wall Street y actualizamos información en titulares con Mirella Calderón y Estefanía Muníz. Terminamos con el balance de la jornada en el que nos acompaña Samuel Abraldes, CEO de Socaire. Con él hablamos del inicio de la semana en los mercados. Una semana que va a estar caracterizada por poco dato macro, por la triple hora bruja del viernes y por las palabras que vayan pronunciando algunos miembros de la Reserva Federal tras la reunión de la semana pasada en la que el FOMC acordó mantener los tipos en el nivel y actual y la actualización del diagrama de puntos mostró la expectativa de la FED de una única bajada de los tipos de interés de aquí a que acabe 2024.

Wondering how companies can and should be leveraging LinkedIn to its fullest potential? In this LinkedIn Live, Tom Whalen and I will dive into the valuable ways companies can use LinkedIn to enhance their success. We will explore how LinkedIn can be a powerful tool for recruiting top talent, recognizing the achievements of your team members or collaborators, and maintaining strong connections with customers and clients. Tom Whalen is a Healthcare Remote Sales Leader with McKesson Corporation, a global healthcare company. For more information: videoeasypeasy.com Gillian Whitney: linkedin.com/in/gillianwhitney Tom Whalen: linkedin.com/in/tomwhalen

About Ken Washington:Ken Washington brings over three decades of experience in leading technical endeavors for Fortune 100 companies, government contractors, and research laboratories. His leadership roles have involved team-building and shaping strategic visions for large organizations. Notably, he was honored as the 2012 Black Engineer of the Year in Research Leadership and later inducted into both the National Academy of Engineers and the Black Engineers Hall of Fame.Currently serving as the Senior Vice President and Chief Technology & Innovation Officer at Medtronic, Ken also holds board positions at McKesson Corporation and SAE International, where he serves as the Automotive Sector VP. He's been a pivotal member of the Internet Ecosystem Innovation Committee and actively engages in strategic collaborations with universities, notably as a member of the Georgia Tech Advisory Board and former chair of the University of Michigan Leadership Advisory Board.Ken's expertise spans diverse domains, from automotive research and space science to information privacy and high-performance computing technologies. He excels in program and project management, guiding new facility projects, and fostering collaborative system development. His track record includes successful executive-level presentations, business plan developments, and resource optimization strategies, making him a sought-after leader in both the public and private sectors.Things You'll Learn:Robotics in surgery enhance precision, consistency, and ergonomics, ultimately improving patient outcomes.AI revolutionizes surgery with personalized pre-procedure planning and real-time guidance for surgeons.The future of surgery lies in the combination of robotics, AI, and digital platforms for personalized care.AI algorithms guide surgeons during surgery, enhancing accuracy and precision in procedures.Medtronic is committed to the future of surgery and healthcare with robotics and AI technologies.Resources:Connect with and follow Ken on LinkedIn.Learn more about Medtronic on their LinkedIn and website.

AI is coming everywhere, and private practice is no exception. What might it look like? How would you get started? Where are some speed bumps? My guest today is deep into this area and will share his insights. James F. Jordan is a healthcare and life sciences expert. He is a Distinguished Service Professor of Health Care and Biotechnology at Carnegie Mellon University's Heinz College, the President of StraTactic, the National Co-Chairman of the BIO Bootcamp, and the Founder of the Healthcare Data Center. He has published numerous articles and books on innovation, startups, intellectual property, and health systems.Jordan has been a senior executive for Fortune 100 companies and has participated in and led angel and venture capital investments. As CEO of the Pittsburgh Life Sciences Greenhouse, where he worked with 493 companies and invested in 93 of them. Jim has held high-ranking positions in Fortune 100 companies such as McKesson Corporation, where he served as Senior Vice President, Johnson & Johnson, where he was Vice President for Marketing, and many other noteworthy ventures.As an author, speaker, and consultant, he works with hospitals, health systems, medical devices, pharmaceuticals, diagnostics, biotechnology, and health IT; Jordan is an active industry expert looking for ways to improve the business of healthcare. In this episode Carl White and Jim Jordan discuss:Specific areas where AI could revolutionize private practicesAddressing Physician Concerns: How can AI address concerns or reluctance among physicians, showcasing its potential to enhance their practice?Practical Guidance for AI Adoption: Practical advice and actionable steps for physicians aiming to integrate AI effectively into their practice while sidestepping common pitfalls.Predictions that will help private practice owners Want to be a guest on PracticeCare?Have an experience with a business issue you think others will benefit from? Come on PracticeCare and tell the world! Here's the link where you can get the process started. Connect with James Jordanhttps://jfjordan.comhttps://stratactic.comhttps://healthcaredata.centerhttps://bootcamp.bioInstagram: @stratacticX/Twitter: @JamesFJordan3YouTube: https://www.youtube.com/channel/UCMwrshkei8cuBeSC0gt-MUALinkedIn: https://www.linkedin.com/in/jamesjordan4/ Connect with Carl WhiteWebsite: http://www.marketvisorygroup.comEmail:  whitec@marketvisorygroup.comFacebook:  https://www.facebook.com/marketvisorygroupYouTube: https://www.youtube.com/channel/UCD9BLCu_i2ezBj1ktUHVmigLinkedIn: http://www.linkedin.com/in/healthcaremktg

With over 30 years experience spanning various industries from manufacturing to high tech, Henri Ward's background is very deeply rooted in growing domestic and global businesses. Ward is currently Chief Operating Officer at B-Direct, the nation's first corporate board preparedness and board placement company singularly focused on preparing and placing US Black executives and Black entrepreneurs on paid corporate boards on the African continent.Prior to B-Direct Ward served as General Manager, Vertical Markets at Fiserv Inc., where he held overall responsibility for the financial, operational and technical performance of a $100M technology business providing Software-as-a-Service across multiple vertical markets. Ward also served as Head of Product Management, Global Consumer Solutions at Equifax Inc., where he led revenue generation, new product development and product & platform life cycle management for the $400M Software-as-a-Service business unit.As Global Vice President, Verint Systems Inc. Ward served as P&L leader of Verint's $700M Software-as-a-Service Enterprise Intelligence business. His professional career also includes McKesson Corporation where he served as Director, Product Management and Business Unit Strategy Leader. Ward's earlier career encompasses leadership roles at US Bank as well as 17 years at General Electric Co. in various roles of increasing responsibility. Ward holds a BSBA in Information Systems from Xavier University, Cincinnati, OH and a Lean Six Sigma, Black Belt certification from General Electric Co. Ward is also a member of the Private Directors Association, a national organization whose mission is to connect board-ready executives and corporate board members with Private Equity, Venture Capitalist and privately held companies for corporate board consideration. Ward and wife Antoinette (Toni) live in the metro Atlanta area.

Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedInEpisode Title:

Rite Aid, one of the largest pharmacy chains in the United States, filed for bankruptcy on Sunday, weighed down by billions of dollars in debt, declining sales and more than a thousand federal, state and local lawsuits claiming it filled thousands of illegal prescriptions for painkillers.The company filed for Chapter 11 bankruptcy protection in New Jersey. Its largest creditors include the pharmaceutical company McKesson Corporation and the insurer Humana Health. The pharmacy has raised $3.45 billion to fund its operations while it is in bankruptcy, during which it expects to continue to operate its stores and serve its customers.The company also appointed a new chief executive, Jeffrey Stein, to lead its restructuring. Mr. Stein is the founder of Stein Advisors, a financial advisory firm that focuses on fixing troubled companies. Elizabeth Burr had been serving as Rite Aid's temporary chief executive since January.Support the show

Lyle Mioduszewski, vice president of population health and payer growth for Ciox Health, is our guest for the latest episode of RISE Radio.In this 26-minute podcast, Mioduszewski discusses social determinants of health (SDoH), data collection and sharing, and best practices for capturing SDoH codes in the medical record.About Lyle Mioduszewski Lyle Mioduszewski is vice president of population health and payer growth for Ciox Health, where he works with risk-bearing entities to understand the utility of social determinants of health data factors, with the goal of improved and equitable outcomes for all individuals. With 20 years of experience throughout the health care continuum, Lyle has clinical expertise in emergency and trauma nursing of adults and pediatric populations, as well as cardiac catheterization and electrophysiology nursing. Lyle has been a leader in the health information technology and medical device industries with previous companies, including McKesson Corporation, PointClickCare (Collective Medical), and Zoll Medical. He is passionate about advancing value-based care modalities, augmenting processes relative to varying health literacies, care collaboration, interoperability, and influencing an end to the opioid epidemic using innovative technologies.  About Ciox HealthCiox Health, a Datavant company, provides leading clinical data technology that empowers greater health by unlocking the potential of data in medical records. The company leverages a ubiquitous network of clinical data connections to connect health care decision-makers simply and securely with the data and hidden insights in patient medical records. Ciox helps customers connect, control, and comply in solving last mile challenges in clinical interoperability. Supporting a range of connectivity needs including risk adjustment, research to revenue cycle, Ciox's solutions include clinical data acquisition, release of information, and coding.  

In episode 102, Coffey and Diane Gallo talk about HR news topics including the soft-skills gap, how remote work may negatively impact younger workers professional growth, and improper use of social media in the hiring process.Links to stuff they talked about are on our website at https://goodmorninghr.com/EP102 and include the following topics:- United States Soft Skills Training Market is Expected to Reach US$ 30.7 Billion by 2028- New Grads Have No Idea How to Behave in the Office. Help Is on the Way.- Gen Z Needs Soft Skill Support from their Employers. - Soft Skills: The Competitive Edge- The emergence of social soft skill needs in the post COVID-19 era.- 10 Skills Robots Can't Replace In The Workplace (Yet)- Professionalism in Virtual Meetings: How It Impacts the Remote Work Debate- What Young Workers Miss Without the ‘Power of Proximity'- NY Federal Reserve says remote employees are less productive.- 7 in 10 hiring managers admit to spying on social media to get answers to illegal interview questions.Good Morning, HR is brought to you by Imperative—premium background checks with fast and friendly service. For more information about our commitment to quality and excellent customer service, visit us at https://imperativeinfo.com. If you are an HRCI or SHRM-certified professional, this episode of Good Morning, HR has been pre-approved for half a recertification credit. To obtain the recertification information for this episode, visit https://goodmorninghr.com. About our Guest:Diane Gallo is currently consulting in Human Resources, Culture, Coaching, and Executive Search. She is the former SVP of HR for McKesson Specialty Health, a multi-billion-dollar business of McKesson Corporation servicing many constituents in the healthcare ecosystem. Prior to McKesson, Ms. Gallo led human resources in multiple healthcare settings including delivery and physician practice management. In addition, she has worked in tech and financial services. Ms. Gallo brings Fortune 5 and start-up experiences leveraging experience and practicality to help scale for profitable growth. She prides herself on strategic business acumen. Her passion is talent management and growing individuals to grow companies. Ms. Gallo holds a BBA in Management from the University of Texas in Austin and a Master of Management Science from Houston Baptist University. She has attended executive development programs at the University of North Carolina, Wharton, and Cornell. She resides in Houston, Texas with her husband and two Vizslas.Diane Gallo can be reached at https://www.linkedin.com/in/dianegallo/ About Mike Coffey:Mike Coffey is an entrepreneur, human resources professional, licensed private investigator, and HR consultant.In 1999, he founded Imperative, a background investigations firm helping risk-averse companies make well-informed decisions about the people they involve in their business.Today, Imperative serves hundreds of businesses across the US and, through its PFC Caregiver & Household Screening brand, many more private estates, family offices, and personal service agencies.Mike has been recognized as an Entrepreneur of Excellence and has twice been named HR Professional of the Year. Additionally, Imperative has been named the Texas Association of Business' small business of the year and is accredited by the Professional Background Screening Association. Mike is a member of the Fort Worth chapter of the Entrepreneurs' Organization and volunteers with the SHRM Texas State Council.Mike maintains his certification as a Senior Professional in Human Resources (SPHR) through the HR Certification Institute. He is also a SHRM Senior Certified Professional (SHRM-SCP).Mike lives in Fort Worth with his very patient wife. He practices yoga and maintains a keto diet, about both of which he will gladly tell you way more than you want to know.Learning Objectives:  Respond to the soft-skills gap in the workplace. Create programs that ensure that young professionals receive the mentoring they need. Create policies to ensure appropriate use of social media in the employee selection process.

In this video, we'll perform a MCK stock analysis and figure out what the company looks like based on the numbers. Is McKesson Corporation one of the best stocks to buy at the current price? Find out in the video above! Global Value's McKesson Corporation stock analysis. Check out Seeking Alpha Premium and score an annual plan for just $119 - that's 50% off! Plus all funds from affiliate referrals go directly towards supporting the channel! Affiliate link - https://www.sahg6dtr.com/H4BHRJ/R74QP/ If you'd like to try Sharesight, please use my referral link to support the channel! https://www.sharesight.com/globalvalue (remember you get 4 months free if you sign up for an annual subscription!) McKesson Corporation ($MCK) | McKesson Corporation Stock Value Analysis | McKesson Corporation Stock Dividend Analysis | MCK Dividend Analysis | $MCK Dividend Analysis (Recorded June 19, 2022) ❖ MUSIC ❖ ♪ "Lift" Artist: Andy Hu License: Creative Commons Attribution 3.0. ➢ https://creativecommons.org/licenses/by/3.0/legalcode ➢ https://www.youtube.com/watch?v=sQCuf... 8 Pillar Analysis Props to Everything Money ➢ https://www.youtube.com/c/EverythingMoney

Our guest Jim Jordan has worked in every healthcare system, from pharma, education, hospitals to IT and biotech.  He joins us to discuss some of the barriers to healthcare across the country and why the system is so confusing and complicated.  We all know there is a major divide between  public health and the actual delivery of healthcare. How did this happen and what can we do to remedy this in the future? So……….what can patients and the general public do to improve the business of healthcare?  It's a great conversation we have sharing our insights from the physician side, and his experiences from the business/education/general population side. Next, as we all know there are a lot of new technologies coming out that may help improve our health, from Apple watches to nanobots…will this be helpful? We talk about some of the trends coming up and what to expect as more of our baby boomer population reaches old age.  More about our Guest: James F. Jordan James F. Jordan is a healthcare and life sciences expert. He is a Distinguished Service Professor of Health Care and Biotechnology at Carnegie Mellon University's Heinz College, the President of StraTactic, the National Co-Chairman of the BIO Bootcamp, and the Founder of the Healthcare Data Center. He has published numerous articles and books on innovation, startups, intellectual property, and health systems. Jordan has been a senior executive for Fortune 100 companies and has participated in and led angel and venture capital investments. As CEO of the Pittsburgh Life Sciences Greenhouse, where he worked with 493 companies and invested in 93 of them. Jim has held high-ranking positions in Fortune 100 companies such as McKesson Corporation, where he served as Senior Vice President, Johnson & Johnson, where he was Vice President for Marketing, and many other noteworthy ventures. As an author, speaker, and consultant, he works with hospitals, health systems, medical devices, pharmaceuticals, diagnostics, biotechnology, and health IT; Jordan is an active industry expert looking for ways to improve the business of healthcare. This combined experience makes Jim a sought-after healthcare expert for reporters and the media. Links! Podcast: https://www.chalktalkjim.com/ Website: https://jfjordan.com/ Healthcare Data center: https://healthcaredata.center/ Socials: Facebook Twitter: LinkedIN Youtube Our Advice! Everything in this podcast is for educational purposes only. It does not constitute the practice of medicine and we are not providing medical advice. No Physician-patient relationship is formed and anything discussed in this podcast does not represent the views of our employers.  The Fine Print! All opinions expressed by the hosts or  guests in this episode are solely their opinion and are not to be used as specific medical advice.  The hosts,  May and Tim Hindmarsh MD, BS Free MD LLC, or any affiliates thereof are not under any obligation to update or correct any information provided in this episode. The guest's statements and opinions are subject to change without notice. Thanks for joining us! You are the reason we are here.  If you have questions, reach out to us at doc@bsfreemd.com or find Tim and I on Facebook and IG. Please check out our every growing website as well at  bsfreemd.com (no www)  GET SOCIAL WITH US! Website: bsfreemd.com Rumble: https://rumble.com/search/video?q=bsfreemd Instagram:: https://www.instagram.com/bsfreemd/ Facebook: https://www.facebook.com/bsfree Coming Soon: YouTube Channel!

What is the future of American capitalism? Bill Haslam, former Governor of Tennessee and the Sammons Enterprises Fellow at the Bush Institute; Larry Summers, the Charles W. Eliot University Professor and President Emeritus at Harvard University and former U.S. Treasury Secretary; McKesson Corporation's CEO Brian Tyler, and Mary Moore Hamrick, the Don Evans Family Managing Director of Domestic Policy at the Bush Center, explored what's next for our economy.Related2023 Forum on Leadership

Business Model Innovation with James Jordan | CEO, StraTactic + Professor, Carnegie MellonJames F. Jordan, a Distinguished Service Professor of Healthcare and Biotechnology Management and Senior Director of Healthcare and Biotechnology Programs at Carnegie Mellon University's Heinz College, and the CEO of StraTactic joins Maureen Shaffer, CEO, Mingletoe, to chat about:·       Brand Definition·       Citation Caution·       Goodbye Queue·       Clients–Not Patients·       Differentiation Vigor·       Amazon + Healthcare·       Precision vs. Personalized·       Drive Not-Sexy Outcomes·       Customer Investor Acquirer·       Why Teach Grandma to Text·       Win Health Care Consumerization·       And much much more!Listen to hear for yourself! Watch to see!

In the hundred-and-seventeenth episode of Collecting Real Estate, we interviewed Tom Staub of Red Oak Development Group.Tom Staub is the CEO and Managing Principal of Red Oak Development Group, a real estate development firm based in Austin, Texas. A self-made man, Tom started his first company at 16 and has founded several successful companies since. Tom's obsession with financial health and wealth accumulation began with his humble beginnings after seeing his family struggle financially. In college, Tom grew more interested in investing and founded an investment club before earning his undergraduate degree in finance and an MBA in securities, law, and corporate finance. Before his real estate career, Tom amassed an unparalleled wealth of experience in the corporate world while working with some of the world's top employers in wealth management, corporate finance, pharmaceuticals, and technology. He has managed a $16 billion portfolio of 28 deals, helped multiple companies increase revenue by as high as 80%, and developed a pricing model for the largest pharmaceutical company, resulting in a patent for the logic used, which McKesson Corporation purchased. In 2010, Tom entered the real estate industry as a real estate investor after recognizing the potential in single-family distressed assets. As a result, he amassed a team, bought real estate in three states over four years, and was invited to speak at numerous real estate investing events. After attracting the attention of 45+ investors who wanted to invest their capital, Tom founded an asset management company focused on private money loans, real estate flipping, and multi-family syndications.Tom is a savvy businessman who knows when to leverage market shifts. So when the single-family rental market began to grow too competitive, Tom pivoted his focus on larger projects with more significant margins and lower risk. This led him to partner with his father on two successful syndication projects In Ohio and Alabama, which they exited in under 15 months with 3X multiples on equity. As the market turned again in 2017, Tom and his team switched to land development. They bought 80 acres in Flagstaff, Arizona, to get land development experience. They made some mistakes, but their willingness to assume risks and invest their own capital allowed them to exit in 18 months and triple their investment. After their second successful land development deal,  Tom launched Red Oak Development Group in Austin, Texas, in 2020, which includes ViewPoint Engineering Group under their umbrella.Today, Tom is the CEO and Managing Principal of Red Oak Development Group, overseeing project underwriting, financial planning, debt and equity strategy, company expansion, and project development. Tom has 15 years of business expertise and focuses on project viability, partnerships, and investor relations. Red Oak has funded eight projects and has six active projects with 489 acres and 2,200 lots, with a total valuation of $188M.Tom is a pioneer among outdated developers in Austin, Lockhart, and Luling, Texas. He aims to build new communities with plenty of green space and amenities that enhance city aesthetics.tom@redoakvc.comhttps://redoakvc.com/

By stepping out of our comfort zone, we encounter diverse outcomes and have the potential to discover aspects of ourselves we had never considered before. That can look like striking up a conversation with someone new, attempting a recipe that seems above your skill level, volunteering to take on a project at work you've never done before, or even changing career paths. In this episode, we speak with Lori Schechter, EVP, Chief Legal Officer & General Counsel at McKesson Corporation, about what it takes to step out of your comfort zone, how she navigated her chapter two, and the wisdom she's gained. We discuss: Stepping out of your comfort zone Navigating company initiatives What makes a quality law firm partner   Hear more stories by subscribing to Innovative Legal Leadership on Apple Podcasts, Spotify, or any podcast platform. Listening on a desktop & can't see the links? Just search for Innovative Legal Leadership in your favorite podcast player.

By stepping out of our comfort zone, we encounter diverse outcomes and have the potential to discover aspects of ourselves we had never considered before. That can look like striking up a conversation with someone new, attempting a recipe that seems above your skill level, volunteering to take on a project at work you've never done before, or even changing career paths. In this episode, we speak with Lori Schechter, EVP, Chief Legal Officer & General Counsel at McKesson Corporation, about what it takes to step out of your comfort zone, how she navigated her chapter two, and the wisdom she's gained. We discuss: Stepping out of your comfort zone Navigating company initiatives What makes a quality law firm partner   Hear more stories by subscribing to Innovative Legal Leadership on Apple Podcasts, Spotify, or any podcast platform. Listening on a desktop & can't see the links? Just search for Innovative Legal Leadership in your favorite podcast player.

If Pittsburgh's tech industry had its own Pantheon or Hall of Fame honoring the people who worked tirelessly to make it what it is today, Rich Lunak, President and CEO of Innovation Works (IW), would have a prime seat with all of the trimmings. As a technologist, entrepreneur, business leader and investor, Lunak has been at every side of the technology company creation/innovation table over the last 30 years. In short, he's a legend around here. Prior to joining Innovation Works, Lunak was a successful technology entrepreneur/inventor who built Automated Healthcare, one of Pittsburgh's most successful and enduring technology startups. He helped lead it from a three-person startup to an acquisition by McKesson Corporation where he became the architect of several disruptive growth strategies that helped McKesson launch businesses that became market leaders in multiple segments. At the helm of IW, one of the nation's most active early-stage investors, Lunak synthesized his decades of experience to lead the organization's efforts to provide business expertise, seed capital and other resources to high-potential, technology start-up companies in Pittsburgh. Lunak announced his retirement from IW this spring, easily punching his ticket to the mythical Pittsburgh Tech Pantheon/Hall of Fame. The Pittsburgh Technology Council, TEQ Magazine and I can't just let Lunak ride off into the sunset toward those imaginary shiny marbled halls without some sort of an exit interview! The TEch Council and TEQ's Jonathan Kersting had to ask Lunak a few questions. Pick his brain on where our tech industry is heading. We had to know what he's proud of and if he has any advice for his yet-to-be-named successor.

What does it mean to be authentically Black in Corporate America? Is it possible? What does it require? Join Brittany Willis, MBA and Chief Privacy Officer of Fortune 500 McKesson Corporation, Faith Knight Myers, Esq. - as they mutually explore their journeys of bringing their Blackness into corporate spaces, how they developed the comfort and confidence to show up authentically Black, and listen as they assert why professionalism and Blackness can coexist and in fact, are one in the same.

Careers are a funny thing. We build them and nurture them and then, for some of us, we switch gears and chase our dream to build a unicorn startup. It can be a scary place for most folks. But when you have an established career in the healthcare space, you've got a lot of leverage that you might not know you can capitalize on. This week, we sit down with John Figueroa, Founder and CEO of Carepath Rx. He shares some of the strategies he used to do just that: chase the dream of a unicorn startup that changes healthcare - for the better. Touching on everything from how to leverage relationships you've built over the years to understanding the criteria and framework for a true unicorn business, John brings it all to the table for listeners. Maybe you've been thinking about how you need a change, or want to make a difference, or would really like to put your idea to the test. Whatever your reasons, if you're considering a change in perspective for your career, you're going to want to tune in! Here are the show highlights: Switching gears from an established career to a startup (7:11) How to leverage your experience (and relationships) to open doors (11:28) Why service innovation is a form of product innovation (14:01) How digital technology can make America healthier (17:39) A breakdown of the unicorn criteria (18:36) Healthcare trends to watch for (23:55) Guest Bio John Figueroa is the Chairman and CEO of CarepathRx, a company providing innovative pharmacy solutions to hospital health systems. In his 30-year career in the healthcare industry, John has served as CEO of Genoa Health, Chairman and CEO of Apria Healthcare Group and Coram LLC, CEO and Board Member of Omnicare, Inc. and President of McKesson Corporation's U.S. Pharmaceutical Group. Honored with the Distinguished Alumnus and Pepperdine Graziadio Business School Inspired Leadership Award, he went on to receive the Supply Chain Executive of the Decade award from the Global Supply Chain Leaders Group (GSCLG) and served as a Commissioned Officer in the United States Army as well as serving with the 12th Special Forces Group. John received his Bachelor's degrees in both English Literature and Political Science from the University of California at Los Angeles, and his Master's Degree in Business Administration from Pepperdine University. If you'd like to know more about John and CarepathRx, visit their website at carepathrxllc.com.

In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, talks with Nancy Flores, Executive Vice President & Chief Information and Technology Officer for McKesson Corporation, about the unique complexities of healthcare – a sector with new entrants, new regulations, consolidation, pricing pressures, and an ageing population that needs ever more healthcare. But alongside the complexities, there are opportunities to disrupt.

The next generation of young professionals who will be leading in business in the coming years are the same people who are leaving the church in massive numbers right now. Meet David Roth with Workmatters who is doing something about it. He will share how he feels he missed such an opportunity in the first twenty years of his professional life by not integrating his faith and work. He has lots of great insights to share on this episode of True North Business. About my guest: David Roth is president and CEO of Workmatters, a national nonprofit organization founded in Fayetteville, Arkansas in 2003 whose 2018 vision is to equip 1,000,000 leaders of faith in 10,000 companies by 2025. After two decades working in public company leadership roles, Roth's passion for integrating faith and work led him to join the founding Board of Directors of Workmatters, a church-based marketplace ministry. Eighteen months later, Roth became the Founder and first employee of Workmatters, the 501(c)3 nonprofit organization. Prior to leading Workmatters, Mr. Roth served in sales and marketing leadership roles in J.B. Hunt Transport, Manugistics and American Software, both supply chain management software providers, and McKesson Corporation. Connect with David Roth on LinkedIn About the host: Following a successful career as CEO, Bobby sold his business to a publicly-traded company.  In what he calls his "second half of life", Bobby seeks to pour Biblically-based principles into growth-minded business leaders.   Through Values-Driven Leadership, Bobby serves as an Executive Coach and Training Consultant for organizations.  He shares many of his principles and practices through a weekly blog, the True North Business podcast, and through three books he has authored: Principled Profits: Outward Success Is an Inside Job, True North Business: A Leader's Guide to Extraordinary Growth and Impact, and The Freedom Paradox: Is Unbridled Freedom Dividing America? Find out more at BobbyAlbert.com

Hello and welcome back to Episode 34 of the Supply Chain Podcast. Thank you for tuning in, don't forget to come back every Friday for new episodes featuring leaders in the supply chain! On this week's episode, we are joined by Katya Hall, Director of Enterprise Analytics at McKesson Corporation. For those who aren't familiar, McKesson is a global healthcare company with the responsibility of pharmaceutical distribution in supply chains, health IT systems and care management tools. Listen along to hear us discuss the importance of advanced data analytics in order to pandemic proof supply chains to avoid the challenges we faced due to COVID-19. Don't forget to subscribe! Check out our socials: LinkedIn: @Supply Chain Digital Twitter: @SupplyChainD

I am currently director of product innovation at McKesson Corporation, a pharmaceutical and healthcare IT company. I work for a technical division, MPTS - Macro Helix, where we create software for hospitals and pharmacies. My primary role is to analyze the industry and discover market problems that we can build software to solve. --- Send in a voice message: https://anchor.fm/thinkfuture/message Support this podcast: https://anchor.fm/thinkfuture/support

Mark is a 5 time CEO & industry veteran with 4+ decades of leadership experience spanning Health IT, Health Services, Big Pharma, Diagnostics, Private Equity, & Venture Back Startups.He is the former President & CEO @ ABILITY, a national leader in cloud-based solutions for the healthcare provider marketplace acquired for $1.2B by Inovalon in 2018 — where he currently serves on The Board of Directors. Prior to his role at ABILITY, Mark focused on private equity and investing initiatives as an industry executive at Freeman Spogli. Previously he served as President & Chief Executive Officer @ BenefitPoint, an early stage Sequoia capital-backed employee benefits technology company, where he also served as its Prior to that, he led several of the most prominent healthcare and information technology companies in the world. Mark served as President & CEO @ McKesson Corporation, a Fortune 10 healthcare services and information technology company; President & Chief Executive Officer @ Novartis Pharmaceuticals Corporation, USA (formerly Sandoz), a research-based pharmaceutical manufacturer; and Chairman, President & CEO @ Red Line Healthcare Corporation, a specialty long-term care distribution and medical billing company. He also served as Chairman of the Board of Directors @ Quidel, a manufacturer of diagnostic testing solutions and as a Board Member of several healthcare and technology companies, including Sunrise Medical, a medical equipment manufacturer; Smile Brands Group, a dental practice management company; Charles Schwab, a financial services company; and Imation, a technology company.Outside of work, you can find Mark pursuing his passion for wine making at Pulido~Walker Cellars and supporting the community through Pulido~Walker Foundation focusing on education for youth at risk.

Mark is a 5 time CEO & industry veteran with 4+ decades of leadership experience spanning Health IT, Health Services, Big Pharma, Diagnostics, Private Equity, & Venture Back Startups.He is the former President & CEO @ ABILITY, a national leader in cloud-based solutions for the healthcare provider marketplace acquired for $1.2B by Inovalon in 2018 — where he currently serves on The Board of Directors. Prior to his role at ABILITY, Mark focused on private equity and investing initiatives as an industry executive at Freeman Spogli. Previously he served as President & Chief Executive Officer @ BenefitPoint, an early stage Sequoia capital-backed employee benefits technology company, where he also served as its Prior to that, he led several of the most prominent healthcare and information technology companies in the world. Mark served as President & CEO @ McKesson Corporation, a Fortune 10 healthcare services and information technology company; President & Chief Executive Officer @ Novartis Pharmaceuticals Corporation, USA (formerly Sandoz), a research-based pharmaceutical manufacturer; and Chairman, President & CEO @ Red Line Healthcare Corporation, a specialty long-term care distribution and medical billing company. He also served as Chairman of the Board of Directors @ Quidel, a manufacturer of diagnostic testing solutions and as a Board Member of several healthcare and technology companies, including Sunrise Medical, a medical equipment manufacturer; Smile Brands Group, a dental practice management company; Charles Schwab, a financial services company; and Imation, a technology company.Outside of work, you can find Mark pursuing his passion for wine making at Pulido~Walker Cellars and supporting the community through Pulido~Walker Foundation focusing on education for youth at risk.

Todd Reiners is a race car enthusiast and philanthropist in Sacramento. He competes in vintage cars and is as passionate about his collection as anyone. Reiners is our guest on Episode #154 of The Weekly Driver Podcast. He discusses his long-time appreciation for cars as well as his fund-raising efforts and a unique, moving experience he shared with those less fortunate. Todd Reiners has several vintage race cars including a 1974 Formula 5000 Vintage Lola T332 As a daily driver, Reiners negotiates Sacramento in a 1994 Honda Accord "with a dent." But it's Reiners' other vehicles he prefers to discuss. They include: * 1971 Detomaso Pantera, 351 CI Cleveland V8 Supercharged 600 HP; * 1972 Plymouth Barracuda, 383 CI V8; * 1974 Formula 5000 Vintage Lola T332 Chevy 305 Stock Block, Lucas McKay Injection 600 HP, 1200 pounds; * 1983 Lotus Esprit Turbo, 2.3 4 Cylinder Lotus 910 285 HP; * 1984 Porsche Carrara, 3.2 Flat 6; * 1985 Ferrari 308 GTSI, 3.0 V8. Todd Reiners: Race Car Driver, Philanthropist About a decade ago, Reiners, the Executive director at HOPE, Inc., who also works for McKesson Corporation and The McClatchy Company, had a keen idea to incorporate his interest in racing with the desire to help the Sacramento community. Reiners wasn't particularly comfortable with the attention, but he agreed to let the Sacramento Bee write an article on his Formula 500 Grand Prix car and its unusual crew. Reiners trained some of his homeless friends to change tires, fuel the car the work on his pit crew during a race. The car was sponsored by Loaves & Fishes, the Sacramento area's largest homeless service provider. Several thousand dollars were raised for the sponsor. And as added karma for the day, Reiners won the race. Please join co-hosts Bruce Aldrich and James Raia as we interview Reiners about his amateur racing career, his enjoyment of working on his cars and his philanthropic interests. The Weekly Driver Podcast encourages and appreciates feedback from our listeners. Please forward episode links to family, friends and colleagues. And you are welcome to repost links from the podcast to your social media accounts. Support our podcast by shopping on Amazon.com. Please send comments and suggestions for new episodes to James Raia via email: james@jamesraia.com. All podcast episodes are archived on www.theweeklydriver.com/podcast Every episode is also available on your preferred podcast platform: Amazon.com Google Play iheartradio iTunes Spotify Stitcher RELATED CONTENT Podcast #114, Indianapolis Motor Speedway Set For Autonomous Race Podcast #131: Greg Griffin Races A Ferrrari, Builds Florida Homes David Letterman: Late Night Comedy, Sex and Race Cars

It’s not uncommon for career-building executives inside the finance realm to obtain an MBA in order to pivot their careers in a new direction. Such was the case for Sachin Patel, who after finding some early success as a systems engineer at IBM Corp. began to study the path before him more closely. “One of the things that you don’t very often get to do as an engineer is to articulate what you did by using the written word or even verbally. Just having this not be a feature of the job was something that began to be evident to me,” says Patel, who as the years passed found the laconic nature of engineering to be in direct conflict with his growing desire to play a more active role in shaping and influencing business strategy. “I looked at two areas—investment banking and strategy consulting—and began pursuing both, which probably wasn’t the best approach from a time management standpoint,” explains Patel, who says that ultimately the numbers—or, as he describes it, “the common wiring between engineering and finance”—drew him toward the world of finance. With an MBA in hand, Patel joined Citigroup and set about developing the relationships and industry insights required to succeed in the investment banking realm, until one day—roughly 4 years after his carefully executed career pivot—he received a call from a friend and business school classmate with a job opportunity. In short order, Patel was accepting a director of finance role with Vantage Oncology, a network of cancer centers and supporting physicians that was quickly expanding across the country. Over the next 4 years, Patel would build and lead Vantage’s FP&A team as he advanced from controller to the CFO office, where in 2016 he ultimately helped to sell the company to McKesson Corporation for $1.2 billion. Looking back, Patel credits his years at Vantage for providing him with consecutive opportunities to prove himself as he climbed steadily upward. Still, he makes clear that his success there was not always obvious. In fact, even before he accepted the position, he needed to confront a potential obstacle that surprisingly had little to do with strategy or Vantage’s financial footing. “An interesting wrinkle was that I reported to the business school classmate who recruited me,” explains Patel, who at first mentions his classmate to highlight the added rewards of having returned to business school but is compelled to emphasize the added complexity of such a relationship. “It was good that we had the baseline of a friendship, but sometimes this can lead to a little more ruffling,” he says, before giving kudos to his classmate as well as to Vantage’s management team for creating an environment where the two friends could both succeed. –Jack Sweeney   Patel: We developed an in-house pricing tool for each of our solutions that we offer. And so based on our experience out of what the different components of the expense were, whether it's human time from the operations team, over to cloud expense that I mentioned, anything else that all gets folded into there, I should say, and then we can set the pricing based on that. And this tool allows them to check each of their contracts, or as they're negotiating they can check those margins using that tool. Ultimately, that goes to our chief growth officer who oversees that, and then if we need to make any additional decisions around that, we meet as a group. But it's become part of the practice, and I think they were actually looking for that being that we are developing new solutions. You're not entirely sure how we should price those in the market when it's a new solution. Many times there's a lot of puts and takes there that you have to consider. And so early on it was a very much live discussion, but now it's part of the standard process, and very much something we follow. We were guarded about that margin profile. We were very particular about it. And then we realized that there's many other components to our numbers that we can manage better to free up those dollars to win more business. And what we were able to do is understand that from a valuation perspective, moving from X to 1.1 X margin may not be as important to us as having higher revenue growth. So let's orient around that. Let's take the additional dollars we have and maybe give a little here, invest a little there, and make sure that we're driving that top line growth. Because ultimately there's a finite universe of health plans and provider groups after which the sales team can go. But once you're in there, the opportunity to sell more is really where the sizzle is. And so it's important to sort of win the day, and that became something that the management team, ranging from operations and engineering over to obviously sales and marketing, everyone could coalesce.

Tom Whalen is a career Inside Sales professional and has been leading sales teams since 2000. As a leader, coach, and mentor, Tom has trained countless sales professionals for industry leading organizations such as: Hewlett-Packard, American Express, Key Corp and McKesson Corporation. Tom has built successful sales teams from scratch, scaled new organizations, turned struggling departments around, and integrated several acquisitions. Tom's passion for developing talent, winning new business and moving the inside sales profession forward has been instrumental in the growth of the companies he's worked for as well as the clients they serve. When Tom isn't growing sales organizations, he loves taking wife Suzanne and two daughters Casey and Sydney to Disneyworld and is a zealous fan of all things wrestling.

James F. Jordan is President/CEO at Pittsburgh Life Sciences Greenhouse and a healthcare professor at Carnegie Mellon University. Mr. Jordan is an accomplished Fortune 20-level executive with strong experience in the industry, consulting, and academia and is a recognized expert in market development and guiding the successful formation of entrepreneurial start-up businesses in the life sciences and healthcare industries. Prior to joining the PLSG, Mr. Jordan served as Senior Vice President of a $3 billion division of McKesson Corporation and at Johnson & Johnson. He has leveraged this experience in several startup ventures and is active on several boards of directors. His experience also includes consulting engagements with numerous companies, including Medtronic, Frost & Sullivan, and Otsuka Pharmaceutical.Most recently, Mr. Jordan published his second book, The Intellectual Property Pyramid Assessment: A Novel Method for Creating a Sustainable Competitive Advantage. This is a complement to his first book, Innovation, Commercialization, and Start-Ups in Life Sciences, which provides expert guidance for start-up life sciences companies, from initiation to exit. His third book, to be published in 2019, is titled, Health Systems: an Overview. This book details the U.S. healthcare system, market, and business models.

Fail Forward Interview with Crystal Lennartz, Vice President of Pharmacy Performance for Health Mart Atlas. Crystal shares insight on both personal setbacks and professional failures that have gotten her to her current position. ResilienceRx: Developing a Trust Team.  Your prescription for resilience is provided by Tammy Rogers, an organizational development expert who co-founded the Meyvn Group. Her expertise in burnout and resiliency translates a research-based approach into usable tools for today's workplace. Biography: Crystal Lennartz is currently the VP, Pharmacy Performance for Health Mart Atlas, McKesson Corporation's managed-care solution. She leads the team responsible for managing a high-performing pharmacy network across ~7,000,100+ independent, small and medium chain pharmacies, nationwide. Previously, Crystal spent six years supporting the Health Mart franchise most recently on their strategy and business development team where she served as Chief Pharmacist. Before joining McKesson in 2012, Crystal worked in and on behalf of community pharmacies including roles with Drug Store News, National Association of Chain Drug Stores, SUPERVALU, and Walgreens. She has both a Doctor of Pharmacy and Master of Business Administration from Drake University after which she completed an APhA-ASHP Accredited Residency in Pharmacy Practice with emphasis in Community Care. Crystal lives in the Columbus, OH area with her husband and two children. About Health Mart Atlas Health Mart Atlas is the managed-care solution for more than 6,900 small and medium chain pharmacies, nationwide. Health Mart Atlas provides its pharmacies with access to narrow networks through strategic contracting, increases pharmacy efficiencies through its consolidated reimbursement processes, and delivers the tools needed to help its pharmacies remain top clinical performers in today's shifting industry. As a market leader in managed-care solutions and support for community pharmacies, Health Mart Atlas provides the expertise and tools needed to help its pharmacies have continued access to patients and the right networks to compete in the evolving market.  About McKesson Corporation McKesson Corporation, currently ranked 5th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients.  For more information, visit mckesson.com. Tammy K. Rogers The Meyvn Group http://www.meyvngroup.com/our-finds/podcasts See omnystudio.com/listener for privacy information.

David is a former Galvanize student and now Data Scientist at McKesson Corporation. Coming from an unsuspecting background, David found his way into the tech industry and never looked back. We dive into his experience as a student in addition to taking a look back at his journey prior to his career in tech. Thanks for joining us for season 2 of Between Two Taps, where we will be featuring students and educators from all around the valley. Enjoy! www.betweentwotapscast.com/ We'd love to hear your feedback! Twitter & Instagram: @Between2Taps SUBSCRIBE ON ITUNES: itunes.apple.com/us/podcast/id1298116967

Ever wonder what it’s like to work on antitrust matters as in-house counsel? In this AT/CP podcast from the ABA Section of Antitrust Law, host Natalie Hayes welcomes Stacy Frazier, Saralisa Brau, and Andrew King, who give their thoughts on how antitrust lawyers can be more involved with in-house counsel, the steps they should take if they want to transition, and the differences between working for a corporation and a law firm. They also advise those interested in the position to look for more opportunities to counsel. Stacy Frazier is the executive counsel for competition law and policy at the General Electric Company. Saralisa Brau is the chief antitrust counsel at McKesson Corporation in Washington, D.C. Andrew King serves as the chief counsel and anti-corruption lawyer at the International Paper Company. (Host) Natalie Hayes is an associate in Weil’s Antitrust/Competition practice group.

This episode is with Philip Parker, Chief Operating Officer, from Coral Health. Coral Health is based in Vancouver Canada and has been building their app with user experience and data interoperability as their focus. They want to bring personalized medicine to the patient via blockchain and SMART on FHIR protocols. •SMART (Substitutable Medical Apps, Reusable Technology) on FHIR (Fast Healthcare Interoperability Resources) protocols •Blockchain benefits •Working with Patient Advocacy groups •Prior Authorization process is wasteful and can be improved with data interoperability between payers and providers. •CoverMyMeds streamlines the medication PA process, electronically connecting providers, pharmacists and plan/PBMs. CoverMyMeds was acquired by McKesson Corporation in 2017 •$1.3 trillion annual healthare spending in US may be categorized as wasteful or of no value to patients- admin complexity, fraud, abuse, poor coordination. •Adverse effects from drug to drug interactions is a major cause of hospital admissions •As a company using a permissioned blockchain, what do you think are some advantages of using a public blockchain? •What does personalized medicine mean to you? •Importance of Longitudinal health data •Many clinical trial recruitment is still being done with train station advertisements- very inefficient/ineffective/expensive •Observational/Longitudinal studies can be drastically improved with a platform like Coral Health Links: Homepage: https://mycoralhealth.com/ Access to the app: https://medium.com/@mycoralhealth/introducing-coral-health-records-the-easiest-way-to-access-control-your-health-records-on-apple-5335127f2fbe For early access to test app, email: info@mycoralhealth.com FHIR Index: https://www.hl7.org/fhir

J M Smith Corporation New Leadership Interviews on the Pharmacy Podcast Network    Saul Factor, RPh named President, Smith Drug Company and Burlington Drug Company; Kevin Welch named President, Integra LTC Solution, LLC and QS/1 J M Smith Corporation has announced that its leading innovative technology solutions will now be under the leadership of Kevin Welch. Saul Factor, RPh, who was the President of QS/1, will lead the wholesale distribution business units Smith Drug Company and Burlington Drug Company. “The decision to align our technology offerings under one leader was made to further enhance our customer focus. Kevin is a highly respected technology leader with a passion for moving pharmacy forward. Under his guidance, QS/1 and Integra customers can expect a commitment to technology excellence and responsiveness,” said Alan Turfe, CEO and Chairman, J M Smith Corporation. “During his time as President of QS/1, Saul led with transparency and a contagious drive to advance customer centricity and business excellence. I am looking forward to what Kevin and Saul will accomplish for our customers in their new roles. “I am excited by this tremendous opportunity,” said Welch. “Aligning all our technology offerings benefits the customers in all of the markets we serve. We will continue to have dedicated teams for each of these markets – long term care, community pharmacy and governmental, while sharing best practices across all of them.” Welch was named Chief Technology Officer for J M Smith Corporation in 2017. In the CTO role, he oversees the development of innovative technology, streamlining the process of bringing pharmacy solutions to market. Welch became part of J M Smith Corporation with the acquisition of Integra, which he founded in 1997. He holds degrees in Mathematics, Computer Science, Operations Research and Engineering Management from Stanford University and has served in senior positions at Genentech, Symantec and Microsoft. During his career he has designed and developed many industry leading software applications and systems. “There is perhaps no one in the industry better prepared to lead Smith Drug Company than Saul Factor,” said Turfe. “Saul is a pharmacist with experience in every facet of the industry, from patient care to manufacturing and distribution to sales and marketing.” “The pharmacy industry is very dynamic and we at Smith Drug Company and Burlington Drug Company are committed to being at the forefront with innovative solutions, leading distribution processes and customer-centric service,” said Factor. “It is important to provide customers with what they need now while also working to address their future needs. I am thrilled to be leading Smith Drug and Burlington Drug with our renowned customer service and I am looking forward to partnering with customers to deliver on the promise of the pharmacy of the future.” Factor spent the first ten years of his career as both a retail and long term care pharmacist before moving into leadership positions with PCS, Eli Lilly and RxAmerica. Prior to joining J M Smith Corporation, he was President, Global Sourcing and Generics at McKesson Corporation. A native of New York, Factor earned a BS in pharmacy from Northeastern University in Boston and an MBA from University of New Haven. ABOUT J M SMITH CORPORATION J M Smith Corporation, headquartered in Spartanburg, is South Carolina's third-largest privately owned company. Today, the corporation is focused in the areas of health care and technology, and operates through multiple business units, including Smith Drug Company, QS/1, Integral Solutions Group, RxMedic Systems, Integra LTC Solutions and Burlington Drug Company. For more information, visit www.JMSmithCorp.com. See omnystudio.com/listener for privacy information.

Is McKesson breaking out back to previous highs? $mck

Interview with Jamie Gramz Vice President of Product Management at McKesson Pharmacy Technology & Services.  About McKesson Pharmacy Technology & Services: You want to run your business your way. McKesson Pharmacy Technology & Services (MPTS) gives you the freedom of choice when it comes to picking the right pharmacy technology for your organization. MPTS pharmacy management software and services are focused on making it easier for you to start, run and expand your pharmacy. The team with leaders like Jamie listen to your needs and help you select the system and services that best align with your pharmacy workflow, business goals and budget. MPTS solutions provide improved efficiency and margins, increased profits, and have led to better overall patient care in retail pharmacies across the country. But that doesn't mean you need every solution or that you share the same goals as other pharmacists. Maybe you want to optimize your business without making big changes. Maybe you want more time to focus on patients. Maybe you want innovation. Or maybe you want a packaged set of proven solutions. No matter what your priorities, we have solutions that can help. Solutions that lead to better health in a way that works for your business and your patients. MPTS will make it easy for you to find the right solutions for your business, by grouping them based on how they can help you achieve specific priorities. Interview with Victor Vercammen, Pharm.D Vice President, Innovation & Industry Relations at Supplylogix LLC About Supplylogix Founded in 2010, Supplylogix applications process millions of transactions every day on behalf of more than 12,000 national and regional retail pharmacies. Supplylogix is a high-growth software company that develops and delivers practical supply chain intelligence solutions for pharmacy and related businesses. Supplylogix, a division of McKesson Corporation, is based in Dallas/Fort Worth, Texas, and services a wide array of healthcare providers nationwide. For more information, visit supplylogix.com. Follow us on Twitter at @supplylogix. See omnystudio.com/listener for privacy information.

Asha Collins, PhD talks about her process of setting strategy and how strategy is shaped by qualitative values as much as quantitative measurement. She also explained how to carefully handle decisions that represent a pivot or shift in the way things are being done by an organization. Dr. Collins has a breadth of experience spanning management consulting, business development, and public policy. At the time of this podcast, she was Vice President at at McKesson Corporation where she led US Clinical Trial Sourcing business. She is currently Head of US Clinical Operations at Genentech. Music from Podington Bear. Use with Creative Commons Attribution-NonCommercial 3.0 License.

As a naturally competitive person, Laureen Seeger thrived throughout her career as a litigator. After law school, she clerked and was offered a job in the Atlanta-based law firm of Morris, Manning & Martin, LLP. In the South during the 1980s, there were virtually no women in courtrooms and she had to fight hard for first chair privileges. 14 years later, she went in-house and eventually became general counsel at McKesson, a massive healthcare supplies provider. Now she is general counsel of American Express in another highly regulated industry requiring strong cybersecurity measures. So what advice does she have to offer from her experience as GC for these two major companies? In this episode of In-House Legal, Randy Milch interviews Laureen Seeger about her path to AMEX, industry regulation and cybersecurity, and the importance of brand trust. It is important, she says, for small- and medium-sized firms to invest in security measures, which often involves educating staff on encryption and best practices. Seeger discusses the regular audits American Express administers to their third party affiliates, the benefits and downfalls of cyber insurance, and how her department prepares the AMEX board of governors with the cyber security  information they need to govern properly. She explains how cyber breaches can be much more expensive than periodically assessing business environment, putting protections in place, fishing internally for employees that need training, and encrypting information. Laureen Seeger is executive vice president and general counsel of American Express Company, a position she assumed in July 2014.  As the corporation’s chief legal officer, Seeger oversees the law, government affairs and corporate secretarial functions for American Express and its subsidiaries. Prior to American Express, Ms. Seeger served as executive vice president, general counsel and chief compliance officer of McKesson Corporation and was with the Atlanta law firm of Morris, Manning & Martin, LLP from 1992 to 2000.

In a personal interview with Dr. Linda Livingstone, John Figueroa, president of McKesson Corporation, U.S. Pharmaceutical Group, discusses his experiences at McKesson and how he creates innovations in the rapidly changing healthcare industry.

John Figueroa, president of McKesson Corporation, U.S. Pharmaceutical Group, discusses the business of innovation in healthcare. (Part 1 of 2)

John Figueroa, president of McKesson Corporation, U.S. Pharmaceutical Group, sits down for an interview with Dr. Linda Livingstone, Dean of the Graziadio School of Business and Management. John also answers various questions from audience members. (Part 2 of 2)

In a personal interview with Dr. Linda Livingstone, John Figueroa, president of McKesson Corporation, U.S. Pharmaceutical Group, discusses his experiences at McKesson and how he creates innovations in the rapidly changing healthcare industry.

John Figueroa, president of McKesson Corporation, U.S. Pharmaceutical Group, discusses the business of innovation in healthcare. (Part 1 of 2)

John Figueroa, president of McKesson Corporation, U.S. Pharmaceutical Group, sits down for an interview with Dr. Linda Livingstone, Dean of the Graziadio School of Business and Management. John also answers various questions from audience members. (Part 2 of 2)

Priscilla Stewart-Jones, Senior Vice President, Human Resources, McKesson Corporation, U.S. Pharmaceutical Group, sits down for an interview with Dr. Linda Livingstone, Dean of the Graziadio School of Business and Management. Priscilla also answers various questions from audience members. (Part 2 of 2)

Priscilla Stewart-Jones, Senior Vice President, Human Resources, McKesson Corporation, U.S. Pharmaceutical Group shares her thoughts and experiences on her 20 years of experience working in the field of human resources. (Part 1 of 2)

In a personal interview with Dr. Linda Livingstone, Priscilla Stewart-Jones, Senior Vice President, Human Resources, McKesson Corporation, U.S. Pharmaceutical Group shares her insight and experiences of human resources, the state of the working economy, and advice for working professionals.

In a personal interview with Dr. Linda Livingstone, Priscilla Stewart-Jones, Senior Vice President, Human Resources, McKesson Corporation, U.S. Pharmaceutical Group shares her insight and experiences of human resources, the state of the working economy, and advice for working professionals.

Priscilla Stewart-Jones, Senior Vice President, Human Resources, McKesson Corporation, U.S. Pharmaceutical Group shares her thoughts and experiences on her 20 years of experience working in the field of human resources. (Part 1 of 2)

Priscilla Stewart-Jones, Senior Vice President, Human Resources, McKesson Corporation, U.S. Pharmaceutical Group, sits down for an interview with Dr. Linda Livingstone, Dean of the Graziadio School of Business and Management. Priscilla also answers various questions from audience members. (Part 2 of 2)